Back to Comparisons
Product Comparison

MDHearing Neo XS vs Sony CRE-C10

Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Uses Official HearAdvisor Lab Data
MDHearing Neo XS Hero
MDHearingSoundScore 2.9Grade C

MDHearing Neo XS

The MDHearing Neo XS is a budget OTC hearing aid featuring an invisible-in-ear design, priced at $397. In our lab testing, it earned a C grade with a SoundScore of 2.9/5, ranking #63 of 65 devices in the OTC hearing aid category. This device presents a mixed performance profile. Its standout strength is excellent feedback handling at 5.0/5, scoring 0.46 points above the category average—meaning users should experience minimal whistling or squealing during everyday use. Own-voice comfort is also solid at 3.2/5, sitting 0.69 points above average, which suggests the device manages occlusion reasonably well for its invisible design. However, speech clarity is a significant weakness. Speech in quiet scored just 1.0/5, falling 1.77 points below the category average, while speech in noise scored 1.0/5, sitting 0.48 points below average. Music streaming scored 0.0/5, coming in 1.92 points below average—indicating this device is not suitable for audio entertainment. These low absolute scores mean users may struggle to achieve meaningful speech benefit in our standardized test conditions. The invisible-in-ear form factor and rechargeable batteries offer convenience, but buyers should weigh this against the limited speech performance. Several competitors in the same price range—including the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5)—deliver substantially better sound quality. The Neo XS may appeal to those prioritizing discretion and feedback-free wear over speech clarity, but most users seeking improved communication would benefit from exploring higher-performing alternatives.

Expert Choice
Expert
Choice
Sony CRE-C10 Hero
SonySoundScore 4.2Grade A

Sony CRE-C10

The Sony CRE-C10 is an invisible-in-ear OTC hearing aid priced at $798, earning an A grade with a SoundScore of 4.2/5 in our lab testing. This places it at #12 of 65 devices in the OTC category, putting it in the top 17% of tested OTC hearing aids. Speech performance is where this device truly shines. Speech in quiet scores an excellent 4.5/5, a full 1.71 points above the category average of 2.79/5. Speech in noise performance at 2.9/5 is mixed in absolute terms, though still 1.39 points above the category average of 1.48/5. These speech clarity strengths have contributed to the CRE-C10 earning Expert's Choice recognition in both 2023 and 2024. The device does have notable limitations. Music streaming scores 0.0/5, which is 1.92 points below the category average—this device is not designed for audio entertainment. Feedback handling scores a solid 3.5/5 in absolute terms, though this is 1.04 points below the category average of 4.54/5. Own-voice comfort is mixed at 2.6/5, essentially matching the category average. The Sony CRE-C10 is best suited for consumers who prioritize speech understanding over streaming capabilities and want a discreet, invisible-in-ear form factor. Those who frequently stream music or media should consider alternatives like the Sony CRE-E10, which scores higher overall in this price range.

Performance metrics

Scale 1-5 (Tuned)

Lab metric by fit

Scale 1-5 (Tuned)

Speech in quietNew
MDHearing Neo XS1.0
Sony CRE-C104.5
Speech in noiseNew
MDHearing Neo XS1.0
Sony CRE-C102.9
Own voice
MDHearing Neo XS3.2
Sony CRE-C102.6
Feedback handling
MDHearing Neo XS5.0
Sony CRE-C103.5
Music streaming
MDHearing Neo XS0.0
Sony CRE-C100.0
Overall fit score
MDHearing Neo XS2.9
Sony CRE-C104.3

Speech level

Adjust input dB (Tuned)

Amplification (REIG)

Insertion gain at 65 dB (Tuned)

Fitting configuration for tuned fit

MDHearing Neo XSSony CRE-C10
Ear CouplingSleeve Vented
Ear CouplingSleeve Closed